कृपया अन्य खोज का प्रयास करें
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers; and FL-301, a monoclonal antibody that targets cells that express Claudin18.2 on their cell surface and is in phase II clinical trial, as well as two preclinical antibody programs, FL-302 and FL-501. Leap Therapeutics, Inc. has an option and license agreement with NovaRock, Adimab, and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Douglas E. Onsi | 52 | 2011 | CFO, General Counsel, Treasurer & Secretary, President, CEO & Director |
Christopher K. Mirabelli | 67 | 2011 | Chairman |
James H. Cavanaugh | 84 | 2016 | Independent Director |
Thomas John Dietz | 57 | 2016 | Lead Independent Director |
Joseph Loscalzo | 70 | 2016 | Independent Director |
William W. Li | 58 | 2017 | Independent Director |
Carl F. Nathan | - | - | Member of Scientific Advisory Board |
David Tuveson | - | - | Member of Scientific Advisory Board |
Nissim Mashiach | 60 | 2017 | Independent Director |
Andrew B Nixon | - | 2021 | Member of Scientific Advisory Board |
Richard B. Gaynor | 73 | 2021 | Member of Scientific Advisory Board |
Eileen M. O’Reilly | - | 2022 | Member of Scientific Advisory Board |
Richard L. Schilsky | 73 | 2022 | Independent Director |
Patricia Martin | 63 | 2023 | Independent Director |
Scott Joseph Antonia | - | 2023 | Member of Scientific Advisory Board |
Christian M. Richard | 54 | 2023 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है